NCT02977637View on ClinicalTrials.gov

MRA With Feraheme in HHT

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Hereditary Hemorrhagic Telangiectasia
Interventions
PROCEDURE

Feraheme MRI/MRA

Trial Locations (1)

90095

UCLA, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02977637 - MRA With Feraheme in HHT | Biotech Hunter | Biotech Hunter